| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aardvark Therapeutics, Inc. (AARD) has 8 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. AARD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 203.9K | $1.11M | - | |
| Other | 70.5K | $382.7K | - | |
| CFO | 70.5K | $382.7K | - | |
| Dir | 61.0K | $331.0K | - | |
| Dir | 61.0K | $331.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Sun Nelson | Chief Financial Officer | Buy | 3,000 | $14.40 | $43,200.00 | +2.8% | -66.7% | - | |
| Dec 11, 2025 | Lee Tien-Li | Chief Executive Officer | Buy | 7,000 | $14.49 | $101,395.00 | +0.5% | -66.7% | - | |
| Sep 15, 2025 | Lee Tien-Li | Chief Executive Officer | Buy | 10,000 | $9.66 | $96,623.60 | +0.3% | +45.4% | - | |
| Sep 12, 2025 | Lee Tien-Li | Chief Executive Officer | Buy | 20,000 | $8.03 | $160,654.00 | +0.4% | +81.7% | - | |
| Sep 9, 2025 | Sun Nelson | Chief Financial Officer | Buy | 6,000 | $8.07 | $48,439.80 | +6.0% | +74.7% | - | |
| Feb 14, 2025 | Lee Tien-Li | Chief Executive Officer | Buy | 16,542 | $16.00 | $264,672.00 | +1.1% | -31.7% | -9.0% | |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund Iv, L.P. | 10% Owner | Buy | 1,250,000 | $16.00 | $20,000,000.00 | +46.9% | -31.7% | -9.0% | |
| Feb 14, 2025 | Sun Nelson | Chief Financial Officer | Buy | 10,000 | $16.00 | $160,000.00 | +11.2% | -31.7% | -9.0% | |
| Feb 14, 2025 | Cormorant Asset Management, LP50 | - | Buy | 187,500 | $16.00 | $3,000,000.00 | +23.4% | -31.7% | -9.0% |